Results 121 to 130 of about 3,065,508 (250)
Scheme 1. Schematic illustration of the synthesis and therapeutic evaluation of PLA‐g‐PAO microspheres (PLA‐g‐PAO‐Ms). Monodisperse PLA microspheres (PLA‐Ms) were initially fabricated via microfluidic technology. Surface grafting of acrylonitrile monomers was subsequently achieved through radiation‐induced graft polymerization, followed by ...
Xingliang Liu +7 more
wiley +1 more source
Contact lens as an emerging platform for ophthalmic drug delivery: A systematic review. [PDF]
Yang H +10 more
europepmc +1 more source
Schematic overview of the in vitro and in vivo evaluation of purpurin in promoting MK maturation and platelet production, through ESR1/PI3K/AKT. ABSTRACT Chemotherapy‐induced thrombocytopenia (CIT) increases bleeding risk and compromises chemotherapy delivery.
Xiaolin Gan +12 more
wiley +1 more source
EYE3DPHANTOM: A Novel 3-D-Printed Ophthalmic Phantom for Advanced Surgical Training
Simulation-based surgical training is essential in ophthalmology; however, existing eye models fail to accurately reproduce the anatomy and biomechanics of the posterior segment, thereby limiting their utility for advanced procedures.
Nada Khaled Mansour +8 more
doaj +1 more source
ABSTRACT Hydration structures govern the properties and functions of hydrogels, yet selectively measuring hydration water in the presence of abundant bulk water remains analytically challenging. Here we applied pressure‐controlled attenuated total reflection infrared spectroscopy (ATR‐IR) combined with multivariate curve resolution (MCR) analysis, a ...
Shoichi Maeda +7 more
wiley +1 more source
Author Correction: Perspective use of bio-adhesive liquid crystals as ophthalmic drug delivery systems. [PDF]
Tarsitano M +6 more
europepmc +1 more source
Abstract Background Oral non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used for analgesia in dogs with spontaneous chronic corneal epithelial defects (SCCEDs). Topical NSAIDs can delay epithelialisation and promote stromal melting, but the safety of systemic NSAIDs in SCCEDs is unknown.
Kaitlyn Scheunemann +2 more
wiley +1 more source
Nanoemulsions as Ophthalmic Drug Delivery Systems [PDF]
Dhahir RK, Al-Nima AM, Al-Bazzaz FY.
europepmc +1 more source
Abstract Objective Medical devices are reviewed by the US Food and Drug Administration (FDA) for safety and effectiveness. Class II devices can receive 510(k) clearance if they are “substantially equivalent” to an existing predicate device. This process can be repeated iteratively, leading to a lineage of predicates for newly cleared devices.
Yiting Lin +3 more
wiley +1 more source
Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment. [PDF]
Shen J +19 more
europepmc +1 more source

